del Casale, A.; Paolini, M.; Gentile, G.; Borro, M.; Zocchi, C.; Fiaschè, F.; Padovano, A.; Zoppi, T.; Modesti, M.N.; De Luca, O.;
et al. Dopamine DRD2 and DRD3 Polymorphisms Involvement in Nicotine Dependence in Patients with Treatment-Resistant Mental Disorders. J. Pers. Med. 2022, 12, 565.
https://doi.org/10.3390/jpm12040565
AMA Style
del Casale A, Paolini M, Gentile G, Borro M, Zocchi C, Fiaschè F, Padovano A, Zoppi T, Modesti MN, De Luca O,
et al. Dopamine DRD2 and DRD3 Polymorphisms Involvement in Nicotine Dependence in Patients with Treatment-Resistant Mental Disorders. Journal of Personalized Medicine. 2022; 12(4):565.
https://doi.org/10.3390/jpm12040565
Chicago/Turabian Style
del Casale, Antonio, Marco Paolini, Giovanna Gentile, Marina Borro, Clarissa Zocchi, Federica Fiaschè, Alessio Padovano, Teodolinda Zoppi, Martina Nicole Modesti, Ottavia De Luca,
and et al. 2022. "Dopamine DRD2 and DRD3 Polymorphisms Involvement in Nicotine Dependence in Patients with Treatment-Resistant Mental Disorders" Journal of Personalized Medicine 12, no. 4: 565.
https://doi.org/10.3390/jpm12040565
APA Style
del Casale, A., Paolini, M., Gentile, G., Borro, M., Zocchi, C., Fiaschè, F., Padovano, A., Zoppi, T., Modesti, M. N., De Luca, O., Pomes, L. M., Brugnoli, R., Ferracuti, S., Girardi, P., Pompili, M., & Simmaco, M.
(2022). Dopamine DRD2 and DRD3 Polymorphisms Involvement in Nicotine Dependence in Patients with Treatment-Resistant Mental Disorders. Journal of Personalized Medicine, 12(4), 565.
https://doi.org/10.3390/jpm12040565
